January 18, 2024/NGX

Following the Court Ordered Meeting held on December 5, 2023, at which the shareholders of GlaxoSmithKline Consumer Nigeria Plc approved the proposed Scheme of Arrangement, GSK Consumer Nigeria hereby notifies that the Company has now received Securities and Exchange Commission’s Formal Approval of the Scheme. 

The order of the Federal High Court sanctioning the Scheme of Arrangement has also been obtained. 

An application for the delisting of the Company’s shares from the NGX will be submitted imminently.